In vitro analysis of hGH secretion in the presence of mutations of amino acids involved in zinc binding

Journal of Molecular Endocrinology

Volumn 39, Issue 1-2, 2007, Pages 163-167

  Iliev, Daniel I ^a   Wittekindt, Nicola E ^a,b   Ranke, Michael B ^a   Binder, Gerhard ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; BETA GALACTOSIDASE; COMPLEMENTARY DNA; GLUTAMINE; HISTIDINE; HUMAN GROWTH HORMONE; ZINC ION;

ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CONTROLLED STUDY; DELETION MUTANT; ENZYME ACTIVITY; EXPRESSION VECTOR; GENETIC TRANSFECTION; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HYPOPHYSIS CELL; HYPOTHESIS; IN VITRO STUDY; MUTATIONAL ANALYSIS; NONHUMAN; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; TRINUCLEOTIDE REPEAT; WILD TYPE;

AMINO ACIDS; ANIMALS; BETA-GALACTOSIDASE; BINDING SITES; CELL LINE, TUMOR; GENETIC VECTORS; HUMAN GROWTH HORMONE; HUMANS; MUTANT PROTEINS; MUTATION; PROTEIN BINDING; RADIOIMMUNOASSAY; TRANSFECTION; ZINC;

EID: 34548348998     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-07-0039     Document Type: Article

References (22)

1. Berg JM & Shi Y 1996 The galvanization of biology: a growing appreciation for the roles of zinc. Science 271 1081-1085.
2. Binder G & Ranke MB 1995 Screening for growth hormone (GH) gene splice-site mutations in sporadic cases with severe isolated GH deficiency using ectopic transcript analysis. Journal of Clinical Endocrinology and Metabolism 80 1247-1252.
3. Binder G, Brown M & Parks JS 1996 Mechanisms responsible for dominant expression of human growth hormone gene mutations. Journal of Clinical Endocrinology and Metabolism 81 4047-4050.
4. Binder G, Keller E, Mix M, Massa GG, Stokvis-Brantsma WH, Wit JM & Ranke MB 2001 Isolated GH deficiency with dominant inheritance: new mutations, new insights. Journal of Clinical Endocrinology and Metabolism 86 3877-3881.
5. Carroll RJ, Hammer RE, Chan SJ, Swift HH, Rubenstein AH & Steiner DF 1988 A mutant human proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway. PNAS 85 8943-8947.
6. Cogan JD, Phillips JA, Schenkman SS, Milner RD & Sakati N 1994 Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomeric protein. Journal of Clinical Endocrinology and Metabolism 79 1261-1265.
7. Cunningham BC, Mulkerrin MG & Wells JA 1991 Dimerization of human growth hormone by zinc. Science 253 545-548.
8. Deladoey J, Stocker P & Mullis PE 2001 Autosomal dominant GH deficiency due to an Arg183His GH-1 gene mutation: clinical and molecular evidence of impaired regulated GH secretion. Journal of Clinical Endocrinology and Metabolism 86 3941-3947.
9. Duquesnov P, Simon D, Netchine I, Dastot F, Sobrier ML, Goossens M, Czernichow P & Amselem S 1998 Familial isolated growth hormone deficiency with slight height reduction due to a heterozygote mutation in GH gene. Proc. 80th Meeting of The Endocrine Society P2-202 (Abstract).
10. Gertner JM, Wajnrajch MP & Leibel RL 1998 Genetic defects in the control of growth hormone secretion. Hormone Research 49 9-14.
11. Hauffa BP, Lehmann N, Bettendorf M, Mehls O, Dorr HG, Partsch CJ, Schwarz HP, Stahnke N, Steinkamp H, Said E et al. 2004 Central reassessment of GH concentrations measured at local treatment centers in children with impaired growth: consequences for patient management. European Journal of Endocrinology 150 291-297.
12. Ho SN, Hunt HD, Horton RM, Pullen JK & Pease LR 1989 Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77 51-59.
13. Iliev DI, Wittekindt NE, Ranke MB & Binder G 2005 Structural analysis of human growth hormone with respect to the dominant expression of GH mutations in isolated growth hormone deficiency type II. Endocrinology 146 1411-1417.
14. Lee MS, Wajnrajch MP, Kim SS, Plotnick LP, Wang J, Gertner JM, Leibel RL & Dannies P 2000 Autosomal dominant growth hormone (GH) deficiency type II: the Del32-71-GH deletion mutant suppresses secretion of wild-type GH. Endocrinology 141 883-890.
15. McGuinness L, Magoulas C, Sesay AK, Mathers K, Carmignac D, Manneville JB, Christian H, Philips JA, III & Robinson IC 2003 Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice. Endocrinology 144 720-731.
16. Moore HH & Kelly RB 1986 Re-routing of a secretory protein by fusion with human growth hormone sequences. Nature 321 443-446.
17. Mullis PE, Robinson IC, Salemi S, Eble A, Besson A, Vuissoz JM, Deladoey J, Simon D, Czernichow P & Binder G 2005 Isolated autosomal dominant growth hormone deficiency: an evolving pituitary deficit? A multicenter follow-up study Journal of Clinical Endocrinology and Metabolism 90 2089-2096.
18. 2+ and pH. Endocrinology 143 1302-1309.
19. Scammell JG, Burrage TG & Dannies PS 1986 Hormonal induction of secretory granules in a pituitary tumor cell line. Endocrinology 119 1543-1548.
20. 2+. Molecular Endocrinology 11 1544-1551.
21. Ultsch MH, Somers W, Kossiakoff AA & de Vos AM 1994 The crystal structure of affinity-matured human growth hormone at 2 A resolution. Journal of Molecular Biology 236 286-299.
22. Yang TH, Cleland JL, Lam X, Meyer JD, Jones LS, Randolph TW, Manning MC & Carpenter JF 2000 Effect of zinc binding and precipitation on structures of recombinant human growth hormone and nerve growth factor. Journal of Pharmaceutical Sciences 89 1480-1485.